Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Capital Spending

Governor Christie Signs Bill Appropriating $34 Million for Higher Education Construction

Governor Chris Christie

Trenton, NJ, March 24, 2017 — Gov. Chris Christie on March 14 signed legislation, strongly supported by the New Jersey Business & Industry Association, appropriating the remaining $34 million from a voter-approved bond issue for construction projects at higher education institutions.

The appropriation is the balance remaining from the $750 million Building Our Future Bond Act that voters approved in 2012.

The 32 colleges and universities whose proposals won state-approval for this latest round of funding had to detail how their projects served students and aligned with New Jersey’s workforce needs. Continue reading

NJ Colleges’ Building Projects to Benefit from $34 Million Allocation from 2012 ‘Building Our Future Bond Act’

NJ SpotlightTrenton, NJ, January 23, 2017 — John Reitmeyer reports on NJ Spotlight that it has been more than four years since voters authorized a major bond issue to help pay for new buildings and renovations at New Jersey colleges and universities.

Now, lawmakers are taking steps to allocate $34 million, which represents the remaining dollars that have yet to be spent from that bond issue.

Committees in both the Assembly and Senate voted last week to approve a list of projects that will use up what remains of the $750 million “Building Our Future Bond Act” from 2012. Continue reading

New Jersey Alliance for Action to Host ‘Building Our Future’ Briefing on June 12

Edison, NJ, June 5, 2014 — The New Jersey Alliance for Action will host a briefing on “Building Our Future: NJ Higher Education Capital Construction” on Thursday morning, June 12 at PNC Bank Arts Center in Holmdel.

Featured speaker Joel S. Bloom, the President of New Jersey Institute of Technology (NJIT), will detail $230 million worth of upcoming construction work at NJIT.

In addition, New Jersey Higher Education Secretary Rochelle Hendricks will speak. Continue reading

HINJ Releases 2013 Economic Impact Report and ‘HINJ and NJ’s Life Sciences Community’ Brochure

New Brunswick, NJ, May 13, 2014 — The HealthCare Institute of New Jersey (HINJ) has released two new publications:  the 2013 Economic Impact Report and a new external (leave-behind) brochure entitled HINJ and New Jersey’s Life Sciences Community.

Printed copies of each publication are being mailed to HINJ member companies and to our many stakeholders, including members of New Jersey’s Congressional Delegation, Governor Christie and his administration and the State Legislature. Continue reading

HINJ Member Companies’ Economic Impact Exceeds $26 Billion in 2012, Finds New Study Conducted in Association with Deloitte

New Brunswick, NJ, November 13, 2013 ― Key findings from the HealthCare Institute of New Jersey’s (HINJ) 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.”

According to the study, which was conducted by Deloitte for the ninth consecutive year, participating HINJ member companies had a total impact on New Jersey’s economy of $26.6* billion in calendar year 2012, a healthy increase of 9.9 percent from 2010.

“HINJ member companies continue to be a major force in New Jersey’s economy in their pursuit of advancing global health,” said Dean J. Paranicas, President and Chief Executive Officer of HINJ.  “Our enduring goal is for patients everywhere to have access to the medicines, therapies and medical technologies they critically need.” Continue reading